$MDWD

Rubinstein Samuel sold $7K of MDWD (indirect holdings)

Rubinstein Samuel sold 525 indirectly-held shares of MediWound Ltd. (MDWD) at $12.72 on 2026-09-01.

Original reporting
SEC EDGAR · Rubinstein Samuel
Published Sep 2, 2026, 8:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 2, 2026, 8:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$MDWD
Neutral
high confidence
Mentioned
$MDWD
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MDWDNeutralLow
01

Why it matters

The sale is small relative to market cap, unlikely to move the stock.

02

Market read

Minor insider sale with limited trading relevance.

03

What to watch

Director may have liquidity needs unrelated to company outlook.

Relevance 3/10Novelty 4/10Timing: post-market 2026-09-01

Background

Form 4 filings disclose insider trades; investors monitor them for potential signals.

Company-level read

Ticker impact

$MDWDNeutralHigh confidence
Context

Director Rubinstein Samuel sold 525 shares for $6,678, reducing holdings to zero.

Expected impact

Limited short-term impact; price likely unchanged.

Evidence & confidence

The transaction is a primary Form 4 filing with a small dollar amount, typical for directors exiting positions.

Market effects

No broader sector impact; isolated insider transaction.

None; company is micro‑cap with limited market footprint.

None

Counterpoint

The sale could be a routine portfolio rebalancing rather than a negative signal.

Key entities

  • MediWound Ltd.

    Medical device company listed under MDWD.

  • Rubinstein Samuel

    Director of MediWound Ltd.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MDWDMed

MediWound Ltd. (MDWD): Financial results for Q2 2026

MediWound Ltd. (MDWD) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 MediWound Reports Second Quarter 2026 Financial Results and Provides Corporate Update EscharEx ® Phase III VALUE Trial Advancing; Interim Assessment and Enrollment Completion Expected by End of First Quarter 2027 Master Services Agreement Signed with Vericel Under it

$DELLLow

Silver Lake Partners IV, L.P. (Durban Egon) sold $29.2M of DELL (indirect holdings)

Silver Lake Partners IV, L.P. sold 51,494 indirectly-held shares of Dell Technologies Inc. (DELL) at an average of $567.88 ($561.56–$573.28, $29.24M total) across 13 trades on 2026-09-16. Filed jointly with Silver Lake Technology Associates IV, L.P. (Director), SLTA IV (GP), L.L.C. (Director), Silver Lake Group, L.L.C. (Director) and Durban Egon (Director).